A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM

计划入组 49 人 · 首次发布于 2023 年 3 月 9 日

A Phase 3 Clinical Study of KHK 4827

计划入组 155 人 · 首次发布于 2014 年 2 月 3 日

Evaluating a Water Quality Assurance Fund Intervention in Ghana and Kenya

计划入组 4,800 人 · 首次发布于 2024 年 8 月 26 日

KHK-6

KHK-2898

KHK-1334

Thrasher Research Fund

United States

The Jimmy Fund

United States

NINEPOINT TARGET INCOME FUND

Syneron Bio Secures Nearly $100M Series A Funding for Macrocyclic Peptide Platform

TandemAI Secures $22M Series A Extension to Advance AI-Powered Drug Discovery Platform

FDA Approves Resmetirom (REZDIFFRA™) as First Treatment for NASH